Several other research analysts have also commented on the stock. BMO Capital Markets upped their price objective on shares of Aetna from $175.00 to $200.00 and gave the stock a market perform rating in a report on Friday, October 27th. Argus reissued a buy rating and set a $185.00 price objective (up from $165.00) on shares of Aetna in a research report on Tuesday, September 12th. Zacks Investment Research raised shares of Aetna from a hold rating to a strong-buy rating and set a $184.00 price target on the stock in a report on Wednesday, October 25th. Cantor Fitzgerald downgraded shares of Aetna from an overweight rating to a neutral rating in a report on Thursday, October 26th. Finally, BidaskClub downgraded shares of Aetna from a strong-buy rating to a buy rating in a report on Wednesday, July 19th. Eleven equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. Aetna presently has an average rating of Buy and a consensus target price of $172.36.
Aetna (NYSE:AET) traded down $1.19 during midday trading on Thursday, hitting $171.83. 1,429,000 shares of the stock traded hands, compared to its average volume of 2,441,657. The company has a market capitalization of $56,421.82, a price-to-earnings ratio of 16.95, a P/E/G ratio of 1.58 and a beta of 0.61. Aetna has a one year low of $116.04 and a one year high of $184.98. The company has a current ratio of 0.53, a quick ratio of 0.53 and a debt-to-equity ratio of 0.52.
Aetna (NYSE:AET) last issued its quarterly earnings data on Tuesday, October 31st. The company reported $2.45 EPS for the quarter, beating the consensus estimate of $2.06 by $0.39. Aetna had a net margin of 2.93% and a return on equity of 21.84%. The company had revenue of $14.99 billion during the quarter, compared to analysts’ expectations of $15.12 billion. During the same quarter in the previous year, the company earned $2.07 earnings per share. Aetna’s revenue for the quarter was down 5.0% on a year-over-year basis. equities research analysts expect that Aetna will post 9.78 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which was paid on Friday, October 27th. Stockholders of record on Thursday, October 12th were given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 1.16%. The ex-dividend date was Wednesday, October 11th. Aetna’s dividend payout ratio (DPR) is presently 37.04%.
In other Aetna news, President Karen S. Lynch sold 15,271 shares of the business’s stock in a transaction on Monday, September 18th. The stock was sold at an average price of $161.91, for a total transaction of $2,472,527.61. Following the sale, the president now directly owns 64,261 shares in the company, valued at $10,404,498.51. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Margaret M. Mccarthy sold 10,288 shares of the business’s stock in a transaction on Friday, September 15th. The stock was sold at an average price of $162.85, for a total value of $1,675,400.80. Following the completion of the transaction, the executive vice president now directly owns 33,563 shares of the company’s stock, valued at $5,465,734.55. The disclosure for this sale can be found here. Insiders own 1.14% of the company’s stock.
Institutional investors have recently added to or reduced their stakes in the stock. Guardian Life Insurance Co. of America grew its position in Aetna by 0.7% during the first quarter. Guardian Life Insurance Co. of America now owns 1,353 shares of the company’s stock valued at $173,000 after acquiring an additional 9 shares during the period. Marshall Wace North America L.P. purchased a new stake in Aetna during the first quarter valued at about $16,237,000. Menta Capital LLC purchased a new stake in Aetna during the first quarter valued at about $579,000. Aviance Capital Partners LLC grew its position in Aetna by 34.9% during the first quarter. Aviance Capital Partners LLC now owns 9,212 shares of the company’s stock valued at $1,175,000 after acquiring an additional 2,382 shares during the period. Finally, Meiji Yasuda Asset Management Co Ltd. grew its position in Aetna by 8.4% during the first quarter. Meiji Yasuda Asset Management Co Ltd. now owns 22,107 shares of the company’s stock valued at $2,820,000 after acquiring an additional 1,710 shares during the period. Hedge funds and other institutional investors own 90.93% of the company’s stock.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with our FREE daily email newsletter.